A drug recently approved to prevent migraine may start working right away, according to a new study. The study looked at the drug atogepant, which is a calcitonin gene-related peptide (CGRP) receptor antagonist taken by mouth.
from Top Health News -- ScienceDaily https://ift.tt/LewqCpz
Post a Comment